Category Specific RSS

ASX:MEM

Memphasys Delivers Clinical Milestone as Felix™ Fertility System Clears Key Trial Benchmark

Fertility Tech Market Expands, With Memphasys Ready to Capitalise The global assisted reproductive technology (ART) sector continues to grow rapidly,…

4 months ago

Memphasys Reaches Key Milestone in Felix™ Clinical Trial, Data Lock Expected Soon

Advanced Sperm Selection Technology Moves Closer to Market Memphasys Limited (ASX:MEM) has hit a critical milestone in its pivotal clinical…

5 months ago